Development of a novel CD19 CAR with improved functionality
23 Sep 2016
Development of a novel CD19 CAR with improved functionality
Immune strategies for treating neuroblastoma
Vaccination to improve the persistence of CD19 CAR T cells in relapsed ALL
The timeline of adjuvant and neoadjuvant therapy for melanoma
Targeted therapies in melanoma
Treatment of cutaneous T cell lymphoma
Skin cancer lesions arising in uncommon regions
Developments in checkpoint immunotherapy
Targetted medicine to reduce melanoma mutational burden
VISMO trial to treat basal cell carcinoma
Checkpoint inhibitor therapy for treating melanoma
Drug repurposing in review